News
August 6, 2007 - Boston Scientific Corp. announced that it will not move forward with a public offering of shares of its $1.4 billion surgical devices unit, which earns as much as a fifth of the company's sales, in a plan to reverse a drop in its share price.
August 05, 2007
News
August 6, 2007 – In a statement on The Children’s Health and Medicare Protection Act of 2007 (CHAMP Act) (H.R. 3162), which the House passed with a vote of 225-204 on August 1 of 2007, the American College of Cardiology (ACC) responded to lawmakers, urging them to address serious concerns about this bill’s proposed new physician payment structure.
August 05, 2007News
August 6, 2007 - Atrium Medical Corp., a manufacturer of chest drainage products, announced that its soft and firm ...
August 05, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
August 3, 2007 - Volcano Corp. announced it has received approval by regulatory authorities in Japan to market the ...
August 02, 2007News
August 3, 2007 - World Heart Corp. (WorldHeart), a developer of mechanical circulatory support systems, recently ...
August 02, 2007News
August 3, 2007 – Novation, a healthcare contracting and services company of VHA Inc. and the University HealthSystem Consortium (UHC), awarded ev3 Inc. three, three-year contracts beginning Oct.
August 02, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
August 3, 2007 - CryoCor Inc., a medical device company focused on the treatment of cardiac arrhythmias, announced today that the FDA has granted pre-market approval (PMA) for its Cardiac Cryoablation System for the treatment of right atrial flutter, enabling CryoCor to target over 200,000 U.S. patients treating flutter with cryoablation annually.
August 02, 2007News
August, 3, 2007 - In patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C), there is a high rate of recurrence following radiofrequency (RF) catheter ablation following electrophysiologic mapping, researchers report in the July 31st issue of the Journal of the American College of Cardiology.
August 02, 2007News
August 2, 2007 — Siemens Medical Solutions Diagnostics announced the availability of the ADVIA 1800 chemistry system ...
August 01, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
August 1, 2007 - SonoSite Inc., a developer of portable ultrasound, announced it has acquired LumenVu Inc., a company ...
July 31, 2007News
August 1, 2007 - BioControl Medical announced that cardiologists at University Hospital Mannheim in Germany and at Ospedali Riuniti di Bergamo in Italy have successfully implanted the CardioFit device in the first patients to be enrolled at those sites in BioControl’s international, multi-center clinical study of the CardioFit system, marking an important step for the treatment of advanced conge
July 31, 2007News
August 1, 2007 - Positron Corp. announced that a recent study by The State University of New York at Buffalo reveals that Positron Emission Tomography (PET) scanning when used as the first tool to diagnose heart-vessel blockages, is more accurate, less invasive and cost effective than SPECT imaging.
July 31, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
August 1, 2007 - AGA Medical Corp. (AGA), owner of a European patent (EP 0 808 138) for intravascular occlusion devices ...
July 31, 2007News
July 31, 2007 - GlaxoSmithKline announced the recommendation of an FDA advisory committee to support Avandia’s (rosiglitazone maleate), an oral anti-diabetic medicine, continued availability to patients in the U.S., information which the FDA will consider its final decision-making process.
July 30, 2007News
July 31, 2007 - Implantable defibrillators can reduce the risk of sudden death in high-risk patients with hypertrophic cardiomyopathy, according to a new study conducted at the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute Foundation and published in the July 25 issue of the Journal of the American Medical Association.
July 30, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now